Cargando…

Apatinib Induces Ferroptosis of Glioma Cells through Modulation of the VEGFR2/Nrf2 Pathway

BACKGROUND: Glioma is a common tumor that originated from the brain, and molecular targeted therapy is one of the important treatment modalities of glioma. Apatinib is a small-molecule tyrosine kinase inhibitor, which is widely used for the treatment of glioma. However, the underlying molecular mech...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xia, Liang, Gong, Mingjie, Zou, Yangfan, Wang, Zeng, Wu, Bin, Zhang, Shuyuan, Li, Liwen, Jin, Kai, Sun, Caixing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117021/ https://www.ncbi.nlm.nih.gov/pubmed/35602105 http://dx.doi.org/10.1155/2022/9925919

Ejemplares similares

Combined Diagnostic Significance of Preoperative Serum β2-Microglobulin and Routine Blood Test in Patients with High-grade Glioma and Solitary Brain Metastasis
por: Li, Liwen, et al.
Publicado: (2020)

Hub gene target of glioblastoma: LOX, SERPINH1 and TGFBI
por: Zhang, Shuyuan, et al.
Publicado: (2022)

Apatinib inhibits VEGFR-2 and angiogenesis in an in vivo murine model of nasopharyngeal carcinoma
por: Peng, Qiu-Xia, et al.
Publicado: (2017)

Long non-coding RNA TP73-AS1 is a potential immune related prognostic biomarker for glioma
por: Zhang, Bo, et al.
Publicado: (2021)

Apatinib Promotes Ferroptosis in Colorectal Cancer Cells by Targeting ELOVL6/ACSL4 Signaling
por: Tian, Xiangyang, et al.
Publicado: (2021)

Apatinib monotherapy for advanced VEGFR-2-negative nasopharyngeal carcinoma: A case report
por: Jin, Jun, et al.
Publicado: (2019)

Apatinib promotes autophagy and apoptosis through VEGFR2/STAT3/BCL-2 signaling in osteosarcoma
por: Liu, Kuisheng, et al.
Publicado: (2017)

Phase II trial of VEGFR2 inhibitor apatinib for metastatic sarcoma: focus on efficacy and safety
por: Liao, Zhichao, et al.
Publicado: (2019)

Apatinib triggers autophagic and apoptotic cell death via VEGFR2/STAT3/PD-L1 and ROS/Nrf2/p62 signaling in lung cancer
por: Xie, Chunfeng, et al.
Publicado: (2021)

Case Report: Gastrointestinal PEComa With TFE3 Rearrangement Treated With Anti-VEGFR TKI Apatinib
por: Xu, Jiaming, et al.
Publicado: (2020)

Therapeutic Potential of Apatinib Against Colorectal Cancer by Inhibiting VEGFR2-Mediated Angiogenesis and β-Catenin Signaling
por: Cai, Xiaomin, et al.
Publicado: (2020)

Correction to: Apatinib triggers autophagic and apoptotic cell death via VEGFR2/STAT3/PD-L1 and ROS/Nrf2/p62 signaling in lung cancer
por: Xie, Chunfeng, et al.
Publicado: (2021)

NRF2, a Superstar of Ferroptosis
por: Yan, Ruihan, et al.
Publicado: (2023)

VEGFR-2 Inhibitor Apatinib Hinders Endothelial Cells Progression Triggered by Irradiated Gastric Cancer Cells-derived Exosomes
por: Li, Guangxin, et al.
Publicado: (2018)

Resection of “down-staged” advanced hepatocellular carcinoma after treatment with the VEGFR2 inhibitor apatinib: five cases report
por: Hou, Zhenyu, et al.
Publicado: (2020)

Apatinib affect VEGF-mediated cell proliferation, migration, invasion via blocking VEGFR2/RAF/MEK/ERK and PI3K/AKT pathways in cholangiocarcinoma cell
por: Huang, Manping, et al.
Publicado: (2018)

Nrf2 attenuates ferroptosis-mediated IIR-ALI by modulating TERT and SLC7A11
por: Dong, Hui, et al.
Publicado: (2021)

An Oral Small Molecule VEGFR2 Inhibitor, Apatinib, in Patients with Recurrent or Refractory Cervical Cancer: A Real World Study
por: Li, Ning, et al.
Publicado: (2020)

An innovative NRF2 nano-modulator induces lung cancer ferroptosis and elicits an immunostimulatory tumor microenvironment
por: Hsieh, Chih-Hsiung, et al.
Publicado: (2021)

PDSS2 Inhibits the Ferroptosis of Vascular Endothelial Cells in Atherosclerosis by Activating Nrf2
por: Yang, Kai, et al.
Publicado: (2021)

Multiple Pulmonary Metastases of Recurrent Giant Cell Tumor of Bone with Expression of VEGFR-2 Successfully Controlled by Denosumab and Apatinib: A Case Report and Literature Review
por: Gong, Taojun, et al.
Publicado: (2021)

The Nrf2 induction prevents ferroptosis in Friedreich's Ataxia
por: La Rosa, Piergiorgio, et al.
Publicado: (2020)

Curcumin reverses erastin-induced chondrocyte ferroptosis by upregulating Nrf2
por: Zhou, Yizhao, et al.
Publicado: (2023)

NADPH Oxidase Subunit CYBB Confers Chemotherapy and Ferroptosis Resistance in Mesenchymal Glioblastoma via Nrf2/SOD2 Modulation
por: Su, I-Chang, et al.
Publicado: (2023)

Hypermethylation of the Nrf2 Promoter Induces Ferroptosis by Inhibiting the Nrf2-GPX4 Axis in COPD
por: Zhang, Zixiao, et al.
Publicado: (2021)

A pilot study of neoadjuvant combination of anti-PD-1 camrelizumab and VEGFR2 inhibitor apatinib for locally advanced resectable oral squamous cell carcinoma
por: Ju, Wu-tong, et al.
Publicado: (2022)

Targeting Nrf2 to Suppress Ferroptosis and Mitochondrial Dysfunction in Neurodegeneration
por: Abdalkader, Moataz, et al.
Publicado: (2018)

Deferoxamine Alleviates Osteoarthritis by Inhibiting Chondrocyte Ferroptosis and Activating the Nrf2 Pathway
por: Guo, Zhou, et al.
Publicado: (2022)

The role m(6)A RNA methylation is CNS development and glioma pathogenesis
por: Pan, Ting, et al.
Publicado: (2021)

Association of the VEGFR2 single nucleotide polymorphism rs2305948 with glioma risk
por: Sun, Shushu, et al.
Publicado: (2022)

Triptolide promotes ferroptosis by suppressing Nrf2 to overcome leukemia cell resistance to doxorubicin
por: Wu, Xia, et al.
Publicado: (2022)

Gremlin inhibits UV-induced skin cell damages via activating VEGFR2-Nrf2 signaling
por: Ji, Chao, et al.
Publicado: (2016)

Corrigendum: Deferoxamine alleviates osteoarthritis by inhibiting chondrocyte ferroptosis and activating the Nrf2 pathway
por: Guo, Zhou, et al.
Publicado: (2023)

Nrf2 and Ferroptosis: A New Research Direction for Neurodegenerative Diseases
por: Song, Xiaohua, et al.
Publicado: (2020)

NRF2 connects Src tyrosine kinase to ferroptosis resistance in glioblastoma
por: Cirotti, Claudia, et al.
Publicado: (2023)

PAQR3 inhibits proliferation and aggravates ferroptosis in acute lymphoblastic leukemia through modulation Nrf2 stability
por: Jin, Ling, et al.
Publicado: (2021)

Atorvastatin Induces Mitochondria-Dependent Ferroptosis via the Modulation of Nrf2-xCT/GPx4 Axis
por: Zhang, Qi, et al.
Publicado: (2022)

Targeting NRF2 uncovered an intrinsic susceptibility of acute myeloid leukemia cells to ferroptosis
por: Liu, Xin, et al.
Publicado: (2023)

IL‑37 suppresses macrophage ferroptosis to attenuate diabetic atherosclerosis via the NRF2 pathway
por: Xu, Jinmei, et al.
Publicado: (2023)

An open label, single-armed, exploratory study of apatinib (a novel VEGFR-2 tyrosine kinase inhibitor) in patients with relapsed or refractory non-Hodgkin lymphoma
por: Li, Ling, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_u3jvavv3spf57r3fk7upc6vqi5